Related content

Alpha-particle radioimmunotherapy with astatine-211 and bismuth-213

By Lucignani Giovanni  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Iss. 9, 2008-09 ,pp. : 1729-1733

Springer Publishing Company

Access to resources Recommend Favorite

Cell-penetrating peptides and antibodies: a new direction for optimizing radioimmunotherapy

By Jain Maneesh   Venkatraman Ganesh   Batra Surinder  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 7, 2007-07 ,pp. : 973-977

Springer Publishing Company

Access to resources Recommend Favorite

Assessment of the short-lived non-pure positron-emitting nuclide ¹²⁰I for PET imaging

By Herzog H.   Qaim S.   Tellmann L.   Spellerberg S.   Kruecker D.   Coenen H.  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 33, Iss. 11, 2006-11 ,pp. : 1249-1257

Springer Publishing Company

Access to resources Recommend Favorite

High-quality ¹²⁴I-labelled monoclonal antibodies for use as PET scouting agents prior to ¹³¹I-radioimmunotherapy

By Verel Iris   Visser Gerard   Vosjan Maria   Finn Ronald   Boellaard Ronald   Dongen Guus  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 12, 2004-12 ,pp. : 1645-1652

Springer Publishing Company

Access to resources Recommend Favorite

EANM procedure guideline for radio-immunotherapy for B-cell lymphoma with ⁹⁰Y-radiolabelled ibritumomab tiuxetan (Zevalin)

By Tennvall Jan   Fischer Manfred   Bischof Delaloye Angelika   Bombardieri Emilio   Bodei Lisa   Giammarile Francesco   Lassmann Michael   Oyen Wim   Brans Boudewijn  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 4, 2007-04 ,pp. : 616-622

Springer Publishing Company

Access to resources Recommend Favorite